Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs4521584 | chr6:42608187 | T/C | 3.4E-8 | 131 | 37.7 | 51.67 | 20.6 | KM Plot |
| TGCT | rs452216 | chr17:39340597 | G/A | 7.11E-7 | 133 | 13.17 | 46.03 | 42.1 | KM Plot |
| TGCT | rs452531 | chr17:39341158 | G/A | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs452876 | chr12:130760245 | A/C | 8.76E-5 | 134 | 48.87 | 40.57 | 25.1 | KM Plot |
| TGCT | rs453545 | chr17:39340430 | A/G | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs4556910 | chr19:30342679 | A/T | 1.92E-6 | 134 | 20.6 | 54.18 | 37.53 | KM Plot |
| TGCT | rs457920 | chr21:42794758 | A/G | 0.000127 | 134 | NA | 33.22 | 42.03 | KM Plot |
| TGCT | rs4585313 | chr4:37240236 | C/T | 0 | 134 | 0.5 | 29.8 | 46.3 | KM Plot |
| TGCT | rs4588629 | chr5:1798138 | A/G | 3.74E-7 | 134 | 20.6 | 45.83 | 42.18 | KM Plot |
| TGCT | rs4633929 | chr2:121951075 | A/G | 1.0E-8 | 134 | 20.6 | 60.63 | 41.27 | KM Plot |
| TGCT | rs4671224 | chr2:54753991 | C/T | 5.44E-5 | 132 | 45.7 | 44.05 | 22.42 | KM Plot |
| TGCT | rs4671227 | chr2:54790598 | A/G | 5.65E-5 | 133 | 45.7 | 42.27 | 22.42 | KM Plot |
| TGCT | rs4671229 | chr2:54918522 | A/T | 0.000161 | 133 | 45.7 | 41.97 | 25.02 | KM Plot |
| TGCT | rs4671959 | chr2:54796931 | C/A | 5.65E-5 | 133 | 45.7 | 42.27 | 22.42 | KM Plot |
| TGCT | rs4671962 | chr2:54798896 | A/T | 7.09E-5 | 130 | 48.63 | 44.05 | 22.42 | KM Plot |